Zeynab Fakhar - Publications

Affiliations: 
2013-2017 University of KwaZulu-Natal, Berea, KwaZulu-Natal, South Africa 

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Mehrzadi A, Rezaee E, Gharaghani S, Fakhar Z, Mirhosseini SM. A Molecular Generative Model of COVID-19 Main Protease Inhibitors Using Long Short-Term Memory-Based Recurrent Neural Network. Journal of Computational Biology : a Journal of Computational Molecular Cell Biology. PMID 38054946 DOI: 10.1089/cmb.2023.0064  0.321
2022 Hejazi L, Ebadi E, Fakhar Z, Nazari M, Rezaee E, Tabatabai SA. Synthesis, Docking Study and Biological Evaluation of Amide-Based Soluble Epoxide Hydrolase Inhibitors with Novel Secondary Pharmacophore of Pyrimidin-2-ol. Chemistry & Biodiversity. PMID 36152343 DOI: 10.1002/cbdv.202200231  0.301
2022 Boussamba-Digombou KJ, Sandasi M, Kamatou GP, van Vuuren S, Sawicki R, Fakhar Z, Viljoen AM. Investigating the Antituberculosis Activity of Selected Commercial Essential Oils and Identification of Active Constituents Using a Biochemometrics Approach and In Silico Modeling. Antibiotics (Basel, Switzerland). 11. PMID 35884202 DOI: 10.3390/antibiotics11070948  0.324
2021 Fakhar Z, Hejazi L, Tabatabai SA, Munro OQ. Discovery of novel heterocyclic amide-based inhibitors: an integrative approach to targeting soluble epoxide hydrolase. Journal of Biomolecular Structure & Dynamics. 1-15. PMID 33650467 DOI: 10.1080/07391102.2021.1894987  0.309
2021 Khan S, Fakhar Z, Ahmad A. Targeting ebola virus VP40 protein through novel inhibitors: exploring the structural and dynamic perspectives on molecular landscapes. Journal of Molecular Modeling. 27: 49. PMID 33495861 DOI: 10.1007/s00894-021-04682-8  0.422
2021 Fakhar Z, Khan S, AlOmar SY, Alkhuriji A, Ahmad A. ABBV-744 as a potential inhibitor of SARS-CoV-2 main protease enzyme against COVID-19. Scientific Reports. 11: 234. PMID 33420186 DOI: 10.1038/s41598-020-79918-3  0.388
2020 Khan S, Fakhar Z, Hussain A, Ahmad A, Jairajpuri DS, Alajmi MF, Hassan MI. Structure-based identification of potential SARS-CoV-2 main protease inhibitors. Journal of Biomolecular Structure & Dynamics. 1-14. PMID 33210561 DOI: 10.1080/07391102.2020.1848634  0.392
2020 Gupta P, Khan S, Fakhar Z, Hussain A, Rehman MT, AlAjmi MF, Islam A, Ahmad F, Hassan MI. Identification of Potential Inhibitors of Calcium/Calmodulin-Dependent Protein Kinase IV from Bioactive Phytoconstituents. Oxidative Medicine and Cellular Longevity. 2020: 2094635. PMID 32724490 DOI: 10.1155/2020/2094635  0.41
2018 Ntombela T, Fakhar Z, Ibeji CU, Govender T, Maguire GEM, Lamichhane G, Kruger HG, Honarparvar B. Molecular insight on the non-covalent interactions between carbapenems and L,D-transpeptidase 2 from Mycobacterium tuberculosis: ONIOM study. Journal of Computer-Aided Molecular Design. PMID 29845435 DOI: 10.1007/S10822-018-0121-2  0.506
2017 Fakhar Z, Govender T, Maguire GEM, Lamichhane G, Walker RC, Kruger HG, Honarparvar B. Differential flap dynamics in l,d-transpeptidase2 from mycobacterium tuberculosis revealed by molecular dynamics. Molecular Biosystems. PMID 28480928 DOI: 10.1039/C7Mb00110J  0.517
2015 Fakhar Z, Naiker S, Alvez CN, Govender T, Maguire GE, Lameira J, Lamichhane G, Kruger HG, Honarparvar B. A Comparative Modeling and Molecular Docking Study on Mycobacterium Tuberculosis Targets Involved in Peptidoglycan Biosynthesis. Journal of Biomolecular Structure & Dynamics. 1-42. PMID 26612108 DOI: 10.1080/07391102.2015.1117397  0.512
Show low-probability matches.